Pathology study for patients with slides and records
Part of Cancer clinical trials.
This trial uses your stored tissue slides and medical history to build a better pathology research tool. It may help future patients get more accurate diagnoses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have complete pathology slides (tissue samples already taken).
- Your medical records are available and complete.
- Your tissue samples are good quality for analysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial reviews stored tissue slides and medical records to build better computer models for diagnosing diseases. No new treatments are tested.
This trial uses artificial intelligence to analyze your pathology slides, radiology images, and medical records together. It aims to see how well AI can help with diagnosis or treatment planning, and you may qualify if your medical data is available and of good quality.
This study looks at advanced or metastatic pancreatic cancer patients and uses stored tumor tissue to learn what may predict treatment outcomes. You may be able to join if you have had limited prior chemotherapy and can provide an archived tissue sample.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This retrospective study uses existing colorectal cancer imaging and/or preserved tissue samples to support more precise (personalized) research. It may help researchers better understand colorectal cancer over time, but it does not involve new treatment.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
Hear when a new Pancancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.